Abstract
6-Mercaptopurine ribonucleoside 5'-triphosphate was found to be an inhibitor of DNA-dependent RNA polymerases from Escherichia coli and chicken myeloblastosis cells. The inhibitor appears to compete with GTP for its binding to RNA polymerase, resulting in a reduction of RNA chain initiations. Neither 6-mercaptopurine ribonucleoside nor its monophosphate derivative caused the inhibition. These studies suggest that the antineoplastic action of 6-mercaptopurine may in part be owing to the inhibition of the activity of DNA-dependent RNA polymerase, resulting in an inhibition of cellular RNA synthesis.
Original language | English (US) |
---|---|
Pages (from-to) | 503-506 |
Number of pages | 4 |
Journal | Molecular Pharmacology |
Volume | 18 |
Issue number | 3 |
State | Published - Dec 1 1980 |
ASJC Scopus subject areas
- Molecular Medicine
- Pharmacology